Patent · US Active

Pyrrolopyrazoles, potent kinase inhibitors

US8530652B2 · kind B2 · utility

0Cited by
7References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 6, 2011
Grant dateSep 10, 2013
Priority date—
Expiry dateOct 6, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pyrrole pyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.